サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1448070

アシュワガンダ市場：2023～2030年

Ashwagandha Market - 2023-2030

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アシュワガンダ市場：2023～2030年
出版日: 2024年03月08日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界のアシュワガンダ市場は、2022年に8億6,412万米ドルに達し、2030年には1兆3,566億2,000万米ドルに達すると予測され、予測期間2023-2030年のCAGRは5.8%で成長する見込みです。

アシュワガンダは古来より天然のアーユルヴェーダハーブと考えられているため、消費者はアシュワガンダとその製品を非常に採用しています。アシュワガンダは古来より天然のアーユルヴェーダハーブとされており、ストレスや不安に対するアダプトゲン薬として使用されているほか、ガンや糖尿病など様々な病気の治療にも役立っています。したがって、このような要因は、世界のアシュワガンダ市場を促進するのに貢献することができます。

さらに、天然サプリメント製品に対する需要の高まりを受けて、製造企業は消費者のニーズを満たすために革新的な製品を積極的に生み出し、発展しています。例えば、2023年4月、南カリフォルニアを拠点とするサプリメント会社Youtheoryは、ポートフォリオを更新しました。アシュワガンダ＋GABA は、医薬品のGABAを100mg配合しています。眠気を促進することなく、ストレスを克服し、リラックスを促すことが示されています。

スポーツと栄養ベースのアシュワガンダサプリメントとアジア太平洋地域が、世界のアシュワガンダ市場で最大のシェアを占めています。アシュワガンダは古来よりアーユルヴェーダの薬と信じられています。政府とメーカーも市場成長拡大のためにいくつかのイニシアチブを提供しています。

ダイナミクス

アシュワガンダサプリメントの需要増加

消費者は、合成薬の代替ソースを強く求めており、その適応特性がストレスや不安の管理に役立つため、天然サプリメントとしてのアシュワガンダの需要増加に大きく役立つ可能性があります。したがって、アシュワガンダのサプリメントに対する需要の増加は、世界のアシュワガンダ市場の成長を推進しています。

さらに、アシュワガンダをベースとしたサプリメントに対する需要の増加は、メーカーが革新的な製品を生み出す機会を生み出すのに役立ちます。例えば、2021年2月、LupinLife社は男性用のアーユルヴェーダ・エナジー・サプリメント「Be One」を発売しました。これは100％アーユルヴェーダの健康とウェルネスのためのサプリメントで、アシュワガンダを含む天然成分が含まれています。

アーユルヴェーダ医薬品の需要増加

アシュワガンダ抽出物の市場は、アーユルヴェーダ医薬品の需要増加により大きく成長すると予測されています。これらの抽出物は、伝統的にアーユルヴェーダ治療において、にきび、不安、心血管疾患などを含むがこれに限定されない様々な健康状態に対処するために使用されてきた医薬品の天然形態です。

さらに、製造企業は市場規模を拡大するためにアシュワガンダのアーユルヴェーダ製品を発売しています。例えば、2024年1月、Hi-Tech Pharmaceuticals社は、アシュワガンダブランドでAshwaPureを発売しました。この製品は、すべての主要な根の中で最も高い濃度を持ち、不安を軽減し、血糖値、体力、スタミナを低下させるのに役立ちます。

アレルギー反応

アシュワガンダには多くの薬効がありますが、人によってはアレルギーを起こすことがあるので注意が必要です。アレルギー反応は、かゆみや発疹のような軽い症状から、腫れや呼吸困難のような重い反応まで様々です。このため、消費者の数が制限され、市場の成長に影響を与える可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • アシュワガンダサプリメントの需要増加
      • アーユルヴェーダ医薬品の需要増加
    • 抑制要因
      • アレルギー反応
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • KSM-66
  • センソリール
  • ハイドロアルコールアシュワガンダ
  • 粗アシュワガンダ

第8章 製品タイプ別

  • アシュワガンダ根
  • アシュワガンダ葉
  • 根ミックス製品
  • ウィサノライド含有量（1%-10%）
  • その他

第9章 形態別

  • 粉末
  • カプセル
  • 錠剤
  • 液体

第10章 機能別

  • スタミナ向上
  • 免疫力の向上
  • 全体的な健康状態
  • 不安とストレスの軽減
  • 脳の健康
  • 筋力
  • その他

第11章 流通チャネル別

  • ハイパーマーケット・スーパーマーケット
  • 専門店
  • ドラッグストア・薬局
  • コンビニエンスストア
  • オンライン小売チャネル
  • その他

第12章 用途別

  • 飲食品
  • 医薬品
  • スポーツ栄養
  • その他

第13章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第14章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第15章 企業プロファイル

  • Baldwa group
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Sami-Sabinsa Group
  • Dabur India Ltd
  • Himalaya Wellness Company.
  • Swanson
  • Patanjali Ayurved Limited
  • Kerry Group plc
  • KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • Bioprex Labs
  • Medikonda Nutrients.

第16章 付録

目次
Product Code: FB8146

Overview

Global Ashwagandha Market reached US$ 864.12 million in 2022 and is expected to reach US$ 1356.62 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2023-2030.

Consumers are highly adopting the ashwagandha and their products, as the ashwagandha is considered a natural ayurvedic herb from ancient times. It is highly used as adaptogen medicine for stress and anxiety, it also helps to cure various diseases such as cancer, diabetes, and others. Hence, such factors can contribute to driving the global ashwagandha market.

Furthermore, in response to the growing demand for natural supplement products, manufacturing companies are actively creating and introducing innovative products to meet consumer needs. For instance, in April 2023, Southern California-based supplement company- Youtheory updated its portfolios. Ashwagandha + GABA has 100mg of pharma GABA. It is shown to overcome stress and encourage relaxation, without promoting sleepiness.

The sports and nutrition-based ashwagandha supplements and Asia-Pacific region accounted for the largest share of the global ashwagandha market. Ashwagandha is believed to be the Ayurvedic medicine from ancient times. The government and manufacturers also provide some initiatives to expand the market growth.

Dynamics

Increasing Demand for Ashwagandha Supplements

Consumers are highly seeking alternative sources of synthetic drugs, which can significantly help in increasing the demand for ashwagandha as a natural supplement, as their adaptogenic properties help in managing stress and anxiety. Hence, the increasing demand for ashwagandha supplements is propelling the growth of the global ashwagandha market.

Furthermore, the increased demand for ashwagandha-based supplements can help to create opportunities for manufacturers to create innovative products. For instance, in February 2021, LupinLife company launched an ayurvedic energy supplement for men, Be One. It is a 100% aurvedic health and wellness supplement, which contains natural ingredients including ashwagandha.

Increasing Demand for Ayurvedic Medicines

The market for ashwagandha extracts is predicted to grow significantly due to the increasing demand for ayurvedic medicines. These extracts are a natural form of medicine that have been traditionally used in ayurvedic treatments to address various health conditions, including but not limited to acne, anxiety, and cardiovascular diseases.

In addition, the manufacturing companies are launching ayurvedic products of ashwagandha to expand their market sizes. For instance, in January 2024, Hi-Tech Pharmaceuticals launched AshwaPure under the ashwagandha brand, it has the highest concentration of all major roots, and it helps in reducing anxiety, and lowering blood sugar levels, strength, and stamina.

Allergic Reactions

Ashwagandha has many medicinal properties, but it's important to note that some people may be allergic to it. Allergic reactions can vary from mild symptoms like itching and rash to more severe reactions such as swelling and difficulty breathing. This can potentially limit the number of consumers and impact the growth of the market.

Segment Analysis

The global ashwagandha market is segmented based on type, product type, form, function, distribution channel, application, and region.

Increasing Demand for Natural Sport Nutrition Products

The sports nutrition category holds the largest portion of the global ashwagandha market. The sports supplement industry is increasingly incorporating ashwagandha into various products due to its potential to regulate cortisol levels. This herb can help to assist in managing the stress response associated with intense exercise. Additionally, ashwagandha is gaining attention for its potential contributions to strength and muscle mass improvements, along with a positive impact on cardiovascular health.

Furthermore, as the demand for natural sports supplements is increasing among consumers, manufacturing companies are launching innovative products in their portfolios. For instance, in September 2020, India's sports nutrition brand MuscleBlaze combined the merits of immune and sports nutrition into one product, it launched an ashwagandha-enriched whey protein powder Biozyme Immunity Whey.

Geographical Penetration

Government Initiatives and Product Launches

The Asia-Pacific region shows the dominance in global ashwagandha market, as ashwagandha has been widely used as a medicinal and ayurvedic plant from ancient times in India, consumers in this region are highly adopting these ashwagandha and their based products as it offers various potential health benefits. Hence such cultural inclination toward herbal supplements can help in driving the ashwagandha market.

Furthermore, the regional government is developing new initiatives to meet increasing demand. For instance, in October 2022, the government of India launched the cultivation of the medicinal plant Ashwagandha on a 200-acre plantation in the Dindigul district, India. This project aims to make Dindigul a hub for medicinal plants.

Additionally, the manufacturers of this region are actively supporting the growing demand by developing innovative products. For instance, in December 2021, Wellness Brand Nidra Nutrition, a part of Supercluster Pi launched a product line of stress relief gummies containing 175 mg of Ashwagandha in India.

Competitive Landscape

The major global players in the market include Baldwa Group, Sami-Sabinsa Group, Dabur India Ltd, Himalaya Wellness Company., Swanson, Patanjali Ayurved Limited, Kerry Group plc, KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED, Bioprex Labs, and Medikonda Nutrients.

COVID-19 Impact Analysis

The pandemic had brought a significantly positive impact on the global ashwagandha market. Due COVID-19 virus, the pandemic, and the lockdown situation and restrictions have caused stress and anxiety among consumers the coronavirus also affected the immune system of the patients. Ashwagandha helps in enhancing the immune system, this has increased the demand for the ashwagandha market.

Additionally, during COVID-19 consumers widely started adopting natural and ayurvedic products which has raised the demand for the usage of ashwagandha for various herbal and medicinal products to treat anxiety and other issues, this has raised the sales of ashwagandha and ashwagandha-based products.

By Type

  • KSM-66
  • Sensoril
  • Hydro-Alcoholic Ashwagandha
  • Crude Ashwagandha

By Product Type

  • Ashwagandha Root
  • Ashwagandha Leaf
  • Root Mix Products
  • Withanolides Content (1% -10%)
  • Others

By Form

  • Powder
  • Capsule
  • Pills
  • Liquid

By Function

  • Improve Stamina
  • Improve Immunity
  • Overall Wellbeing
  • Reduces Anxiety and Stress
  • Brain Health
  • Muscle Strength
  • Others

By Distribution Channel

  • Hypermarket/Supermarket
  • Specialty Stores
  • Drug Stores & Pharmacies
  • Convenience Stores
  • Online Retail Channels
  • Others

By Application

  • Food & Beverages
  • Sports & Nutrition
  • Pharmaceutical
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In April 2022, Kerry Group PLC, the taste and nutrition company, announced it had completed the acquisition of U.S.-based Natreon, Inc., a leading supplier of branded Ayurvedic botanical ingredients. The acquisition significantly expands Kerry's leadership position and ProActive Health's portfolio of science-backed branded ingredients which includes ashwagandha, and others furthering the company's technology growth.
  • In December 2021, Glanbia Nutritionals PLC partnered with Ixoreal Biomed Inc. to optimize its KSM-66 Ashwagandha, highly concentrated root extract with NutraShield Technology, to provide functional and application dosage improvements.
  • In September 2022, Nutriventia launched sustained-release Prolanza ashwagandha, the pharmacokinetic study concluded that Prolanza had a higher rate of bioavailability and absorption, and a longer shelf-life than another well-known ingredient.

Why Purchase the Report?

  • To visualize the global ashwagandha market segmentation based on type, product type, form, function, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ashwagandha market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global ashwagandha market report would provide approximately 86 tables, 94 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Product Type
  • 3.3.Snippet by Form
  • 3.4.Snippet by Function
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Application
  • 3.7.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Demand for Ashwagandha Supplements
      • 4.1.1.2.Increasing Demand for Ayurvedic Medicines
    • 4.1.2.Restraints
      • 4.1.2.1.Allergic Reactions
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.KSM-66*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Sensoril
  • 7.4.Hydro-Alcoholic Ashwagandha
  • 7.5.Crude Ashwagandha

8.By Product Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2.Market Attractiveness Index, By Product Type
  • 8.2.Ashwagandha Root*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Ashwagandha Leaf
  • 8.4.Root Mix Products
  • 8.5.Withanolides Content (1% -10%)
  • 8.6.Others

9.By Form

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2.Market Attractiveness Index, By Form
  • 9.2.Powder*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Capsule
  • 9.4.Pills
  • 9.5.Liquid

10.By Function

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.1.2.Market Attractiveness Index, By Function
  • 10.2.Improve Stamina*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Improve Immunity
  • 10.4.Overall Wellbeing
  • 10.5.Reduces Anxiety and Stress
  • 10.6.Brain Health
  • 10.7.Muscle Strength
  • 10.8.Others

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Hypermarket/Supermarket*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Specialty Stores
  • 11.4.Drug Stores & Pharmacies
  • 11.5.Convenience Stores
  • 11.6.Online Retail Channels
  • 11.7.Others

12.By Application

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2.Market Attractiveness Index, By Application
  • 12.2.Food & Beverages*
    • 12.2.1.Introduction
    • 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3.Pharmaceutical
  • 12.4.Sports Nutrition
  • 12.5.Others

13.By Region

  • 13.1.Introduction
    • 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2.Market Attractiveness Index, By Region
  • 13.2.North America
    • 13.2.1.Introduction
    • 13.2.2.Key Region-Specific Dynamics
    • 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.9.1.U.S.
      • 13.2.9.2.Canada
      • 13.2.9.3.Mexico
  • 13.3.Europe
    • 13.3.1.Introduction
    • 13.3.2.Key Region-Specific Dynamics
    • 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.9.1.Germany
      • 13.3.9.2.UK
      • 13.3.9.3.France
      • 13.3.9.4.Italy
      • 13.3.9.5.Russia
      • 13.3.9.6.Rest of Europe
  • 13.4.South America
    • 13.4.1.Introduction
    • 13.4.2.Key Region-Specific Dynamics
    • 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.9.1.Brazil
      • 13.4.9.2.Argentina
      • 13.4.9.3.Rest of South America
  • 13.5.Asia-Pacific
    • 13.5.1.Introduction
    • 13.5.2.Key Region-Specific Dynamics
    • 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.9.1.China
      • 13.5.9.2.India
      • 13.5.9.3.Japan
      • 13.5.9.4.Australia
      • 13.5.9.5.Rest of Asia-Pacific
  • 13.6.Middle East and Africa
    • 13.6.1.Introduction
    • 13.6.2.Key Region-Specific Dynamics
    • 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

  • 14.1.Competitive Scenario
  • 14.2.Market Positioning/Share Analysis
  • 14.3.Mergers and Acquisitions Analysis

15.Company Profiles

  • 15.1.Baldwa group*
    • 15.1.1.Company Overview
    • 15.1.2.Product Portfolio and Description
    • 15.1.3.Financial Overview
    • 15.1.4.Key Developments
  • 15.2.Sami-Sabinsa Group
  • 15.3.Dabur India Ltd
  • 15.4.Himalaya Wellness Company.
  • 15.5.Swanson
  • 15.6.Patanjali Ayurved Limited
  • 15.7.Kerry Group plc
  • 15.8.KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • 15.9.Bioprex Labs
  • 15.10.Medikonda Nutrients.

LIST NOT EXHAUSTIVE

16.Appendix

  • 16.1.About Us and Services
  • 16.2.Contact Us